Cargando…
Crystal structure of Brugia malayi venom allergen-like protein-1 (BmVAL-1), a vaccine candidate for lymphatic filariasis
Brugia malayi is a causative agent of lymphatic filariasis, a major tropical disease. The infective L3 parasite stage releases immunomodulatory proteins including the venom allergen-like proteins (VALs), which are members of the SCP/TAPS (Sperm-coating protein/Tpx/antigen 5/pathogenesis related-1/Sc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893361/ https://www.ncbi.nlm.nih.gov/pubmed/29501266 http://dx.doi.org/10.1016/j.ijpara.2017.12.003 |
_version_ | 1783313298545967104 |
---|---|
author | Darwiche, Rabih Lugo, Fernanda Drurey, Claire Varossieau, Koen Smant, Geert Wilbers, Ruud H.P. Maizels, Rick M. Schneiter, Roger Asojo, Oluwatoyin A. |
author_facet | Darwiche, Rabih Lugo, Fernanda Drurey, Claire Varossieau, Koen Smant, Geert Wilbers, Ruud H.P. Maizels, Rick M. Schneiter, Roger Asojo, Oluwatoyin A. |
author_sort | Darwiche, Rabih |
collection | PubMed |
description | Brugia malayi is a causative agent of lymphatic filariasis, a major tropical disease. The infective L3 parasite stage releases immunomodulatory proteins including the venom allergen-like proteins (VALs), which are members of the SCP/TAPS (Sperm-coating protein/Tpx/antigen 5/pathogenesis related-1/Sc7) superfamily. BmVAL-1 is a major target of host immunity with >90% of infected B. malayi microfilaraemic cases being seropositive for antibodies to BmVAL-1. This study is part of ongoing efforts to characterize the structures and functions of important B. malayi proteins. Recombinant BmVAL-1 was produced using a plant expression system, crystallized and the structure was solved by molecular replacement and refined to 2.1 Å, revealing the characteristic alpha/beta/alpha sandwich topology of eukaryotic SCP/TAPS proteins. The protein has more than 45% loop regions and these flexible loops connect the helices and strands, which are longer than predicted based on other parasite SCP/TAPS protein structures. The large central cavity of BmVAL-1 is a prototypical CRISP cavity with two histidines required to bind divalent cations. The caveolin-binding motif (CBM) that mediates sterol binding in SCP/TAPS proteins is large and open in BmVAL-1 and is N-glycosylated. N-glycosylation of the CBM does not affect the ability of BmVAL-1 to bind sterol in vitro. BmVAL-1 complements the in vivo sterol export phenotype of yeast mutants lacking their endogenous SCP/TAPS proteins. The in vitro sterol-binding affinity of BmVAL-1 is comparable with Pry1, a yeast sterol transporting SCP/TAPS protein. Sterol binding of BmVAL-1 is dependent on divalent cations. BmVAL-1 also has a large open palmitate-binding cavity, which binds palmitate comparably to tablysin-15, a lipid-binding SCP/TAPS protein. The central cavity, CBM and palmitate-binding cavity of BmVAL-1 are interconnected within the monomer with channels that can serve as pathways for water molecules, cations and small molecules. |
format | Online Article Text |
id | pubmed-5893361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-58933612018-10-05 Crystal structure of Brugia malayi venom allergen-like protein-1 (BmVAL-1), a vaccine candidate for lymphatic filariasis Darwiche, Rabih Lugo, Fernanda Drurey, Claire Varossieau, Koen Smant, Geert Wilbers, Ruud H.P. Maizels, Rick M. Schneiter, Roger Asojo, Oluwatoyin A. Int J Parasitol Article Brugia malayi is a causative agent of lymphatic filariasis, a major tropical disease. The infective L3 parasite stage releases immunomodulatory proteins including the venom allergen-like proteins (VALs), which are members of the SCP/TAPS (Sperm-coating protein/Tpx/antigen 5/pathogenesis related-1/Sc7) superfamily. BmVAL-1 is a major target of host immunity with >90% of infected B. malayi microfilaraemic cases being seropositive for antibodies to BmVAL-1. This study is part of ongoing efforts to characterize the structures and functions of important B. malayi proteins. Recombinant BmVAL-1 was produced using a plant expression system, crystallized and the structure was solved by molecular replacement and refined to 2.1 Å, revealing the characteristic alpha/beta/alpha sandwich topology of eukaryotic SCP/TAPS proteins. The protein has more than 45% loop regions and these flexible loops connect the helices and strands, which are longer than predicted based on other parasite SCP/TAPS protein structures. The large central cavity of BmVAL-1 is a prototypical CRISP cavity with two histidines required to bind divalent cations. The caveolin-binding motif (CBM) that mediates sterol binding in SCP/TAPS proteins is large and open in BmVAL-1 and is N-glycosylated. N-glycosylation of the CBM does not affect the ability of BmVAL-1 to bind sterol in vitro. BmVAL-1 complements the in vivo sterol export phenotype of yeast mutants lacking their endogenous SCP/TAPS proteins. The in vitro sterol-binding affinity of BmVAL-1 is comparable with Pry1, a yeast sterol transporting SCP/TAPS protein. Sterol binding of BmVAL-1 is dependent on divalent cations. BmVAL-1 also has a large open palmitate-binding cavity, which binds palmitate comparably to tablysin-15, a lipid-binding SCP/TAPS protein. The central cavity, CBM and palmitate-binding cavity of BmVAL-1 are interconnected within the monomer with channels that can serve as pathways for water molecules, cations and small molecules. Elsevier Science 2018-04 /pmc/articles/PMC5893361/ /pubmed/29501266 http://dx.doi.org/10.1016/j.ijpara.2017.12.003 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Darwiche, Rabih Lugo, Fernanda Drurey, Claire Varossieau, Koen Smant, Geert Wilbers, Ruud H.P. Maizels, Rick M. Schneiter, Roger Asojo, Oluwatoyin A. Crystal structure of Brugia malayi venom allergen-like protein-1 (BmVAL-1), a vaccine candidate for lymphatic filariasis |
title | Crystal structure of Brugia malayi venom allergen-like protein-1 (BmVAL-1), a vaccine candidate for lymphatic filariasis |
title_full | Crystal structure of Brugia malayi venom allergen-like protein-1 (BmVAL-1), a vaccine candidate for lymphatic filariasis |
title_fullStr | Crystal structure of Brugia malayi venom allergen-like protein-1 (BmVAL-1), a vaccine candidate for lymphatic filariasis |
title_full_unstemmed | Crystal structure of Brugia malayi venom allergen-like protein-1 (BmVAL-1), a vaccine candidate for lymphatic filariasis |
title_short | Crystal structure of Brugia malayi venom allergen-like protein-1 (BmVAL-1), a vaccine candidate for lymphatic filariasis |
title_sort | crystal structure of brugia malayi venom allergen-like protein-1 (bmval-1), a vaccine candidate for lymphatic filariasis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893361/ https://www.ncbi.nlm.nih.gov/pubmed/29501266 http://dx.doi.org/10.1016/j.ijpara.2017.12.003 |
work_keys_str_mv | AT darwicherabih crystalstructureofbrugiamalayivenomallergenlikeprotein1bmval1avaccinecandidateforlymphaticfilariasis AT lugofernanda crystalstructureofbrugiamalayivenomallergenlikeprotein1bmval1avaccinecandidateforlymphaticfilariasis AT drureyclaire crystalstructureofbrugiamalayivenomallergenlikeprotein1bmval1avaccinecandidateforlymphaticfilariasis AT varossieaukoen crystalstructureofbrugiamalayivenomallergenlikeprotein1bmval1avaccinecandidateforlymphaticfilariasis AT smantgeert crystalstructureofbrugiamalayivenomallergenlikeprotein1bmval1avaccinecandidateforlymphaticfilariasis AT wilbersruudhp crystalstructureofbrugiamalayivenomallergenlikeprotein1bmval1avaccinecandidateforlymphaticfilariasis AT maizelsrickm crystalstructureofbrugiamalayivenomallergenlikeprotein1bmval1avaccinecandidateforlymphaticfilariasis AT schneiterroger crystalstructureofbrugiamalayivenomallergenlikeprotein1bmval1avaccinecandidateforlymphaticfilariasis AT asojooluwatoyina crystalstructureofbrugiamalayivenomallergenlikeprotein1bmval1avaccinecandidateforlymphaticfilariasis |